Mesco Pharmaceuticals Limited SHARE PRICE [LIVE]
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Sep 19 | Jun 19 |
|---|---|---|
| Promoters (Change:0.00) | 39.3% | 39.3% |
| FIIs (Change:0.00) | 0% | 0% |
| Mutual Funds (Change:0.00) | 0% | 0% |
| Insurance Companies (Change:0.00) | 0% | 0% |
| Other DIIs (Change:0.00) | 0% | 0% |
| Non Institution (Change:0.00) | 60.7% | 60.7% |
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in Mesco Pharmaceuticals Limited
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
MESCOPHARM News
Frequently Asked Questions
Can I buy Mesco Pharmaceuticals Limited (MESCOPHARM) shares?
How do I buy Mesco Pharmaceuticals Limited (MESCOPHARM) from Angel One?
- Direct investment: You can buy Mesco Pharmaceuticals Limited (MESCOPHARM) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Mesco Pharmaceuticals Limited (MESCOPHARM) shares.
About MESCOPHARM
Today's live share price for Mesco Pharmaceuticals Limited is NSE: N/A, BSE: N/A with a current market capitalization of .
Mesco Pharmaceuticals started commercial operations in Jun.'91 by venturing into seed-marketing of bulk drugs and formulations with the objective of later establishing facilities for manufacture of bulk drugs and formulations. It set up a formulation plant to manufacture injectables, syrups, ointments and tablets/capsules. The company in technical partnership with Merz, Germany, introduced two drugs -- Hepa Merz and Viru Merz -- for hepatitis (liver disorder) and herpes respectively. It is now developing drugs for cardio-vascular diseases and Parkinson's disease. Apart from Merz, Mesco has technical agreements with two Chinese companies -- Guilin Pharmaceutical Factory and China Science & Resources Technology Trading Corporation. The company has expanded its marketing network to the CIS, Italy, Germany and Africa. It is setting up a multi-purpose bulk drug plant with sterile technology to manufacture the latest bulk drugs, in technical collaboration with Chementechno, Austria. During 1996-97, the company earned foreign exchange worth Rs 1.25 cr.
Read more
